Jackson Hospital | Partners | SUMMER 2016

13 / 16

13
COMMUNITY
TAGLINE HERE
OUR PATIENTS
Prostate cancer continues to be
a major health concern for men, and es-
pecially men in Alabama. It remains the
second leading cause of cancer-related
death in men. About
1 in 39 men will die
from the disease. Recent
studies have suggested
that more men are di-
agnosed with advanced
or metastatic prostate
cancer, and this may be
related to an overall de-
cline in prostate cancer
screening.
Survival rates
For all stages of
prostate cancer, the
5-year relative
survival rate is
almost
100%.
HOW COMMON
IS PROSTATE
CANCER?
Other than
skin cancer,
prostate cancer
is the most com-
mon cancer in
American men.
RISK OF
PROSTATE CANCER
About 1 man in 7 will
be diagnosed with
prostate cancer dur-
ing his lifetime.
KEY STATISTICS FOR PROSTATE CANCER
Talk to your provider
about your prostate
cancer risk factors and
screening options. Visit
to learn more about
the disease.
Prostate cancer
NEW TECH, faster detection
“Recent advances in technology have
allowed for better screening and better
assessment of prostate cancer risk,” says
Brian Richardson, MD, urologist at The
Jackson Clinic. “Jackson Hospital offers
some of the most advanced technology
available to improve the ability to diag-
nose, stage and treat prostate cancer.”
The new tests include:
• Advanced prostate imaging with the
region’s only 3T MRI, which allows for
more accurate diagnosis and targeted
prostate biopsies.
• Simple blood testing called the
4Kscore that improves the sensitivity
of PSA testing and more accurately
predicts high-grade prostate cancer,
reducing the need for unnecessary
procedures.
• Molecular testing. After a diagnosis
of prostate cancer, we are now able
to further test the prostate cancer
cells at the molecular and cellular
level to determine if the cancer is in-
dolent (slow-growing) or aggressive.
The urology specialists at Jackson
use the latest tools to better diagnose
prostate cancer and determine the best
course of action, whether through con-
tinued monitoring or other treatment.
#1
Brian
Richardson,
MD